COVID-19 infection can present with thrombotic manifestations like PE with no ultrasonographic evidence of lung parenchymal affection. BLUE protocol provides excellent step by step approach for diagnosis of acute dyspnoea. Adding FECHO to BLUE protocol complete the picture and help making solid diagnosis especially in sub-massive and massive PE
Patient in sinus rhythm with dilated cardiomyopathy and low ejection fraction < 35% have a 4% risk of embolic event (1). This is a soft indication for therapeutic anti-coagulation(controversial) (2). Presence of excess Intra-cardiac Smoke-like Echoes increase risk of embolic event and switch the soft indication to strong one
Stevens-Johnson Syndrome (SJS) happen as a result of infection, side effects to medications or of unknown etiology. Carbamazepine is a common cause (SJS). Good history taking is crucial if clinically indicated treatment with carbamazepine. carbamazepine should be avoided with previous history of severe drug reaction like mast cell activation syndrome.